MedTrace Logo

Comparison of Nodal Staging in Endometrial Cancer

NCT04970368 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2024-01-05

No results posted yet for this study

Summary

This study aims to estimate the recurrence-free survival rates in women with endometrial cancer treated with selective versus sentinel node surgical staging.

Conditions

Interventions

PROCEDURE

Sentinel node procedure

Excision of ALL mapped nodes and other suspicious nodes regardless of mapping and label by anatomic location

PROCEDURE

Selective staging

Intraoperative consultation (IOC)

Sponsors & Collaborators

  • Frederick R. Ueland, M.D.

    lead OTHER

Principal Investigators

  • Frederick Ueland, MD · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-05
Primary Completion
2023-06-13
Completion
2023-06-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04970368 on ClinicalTrials.gov